Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germ Cell Neoplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03168594
What this trial is testing

Study to Compare Irinotecan Combined With Cisplatin (IP) Versus Etoposide Combined With Cisplatin (EP) in Advanced and Metastatic Gastrointestinal Pancreatic and Esophageal Neuroendocrine Carcinoma

Who this might be right for
Neuroendocrine Carcinoma
Peking University 66
Early research (Phase 1)Study completedNCT00014456
What this trial is testing

Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Bladder CancerBreast CancerCarcinoma of Unknown Primary+9 more
Dartmouth-Hitchcock Medical Center 35
Early research (Phase 1)UnknownNCT01381822
What this trial is testing

Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors

Who this might be right for
Advanced Renal Cell CarcinomaGastrointestinal Stromal TumorsPancreatic Neuroendocrine Tumors
Threshold Pharmaceuticals 58
Not applicableNot Yet RecruitingNCT07164053
What this trial is testing

Evaluation of Image Quality and Safety of the MyVeo Surgical Visualization Headset During Standard Neurosurgical and Reconstructive Procedures Using Compatible Microscopes.

Who this might be right for
High-Grade Glioma (WHO III-IV)Cerebral Vascular Conditions Requiring Surgical InterventionConditions Requiring Plastic and Reconstructive Surgery
Leica Microsystems (Schweiz) AG 32
Not applicableStudy completedNCT02385253
What this trial is testing

Training Primary Care Physicians to Perform Melanoma Opportunistic Surveillance

Who this might be right for
MelanomaNeviSkin Moles
Northwestern University 89
Very early researchLooking for participantsNCT07268053
What this trial is testing

A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases

Who this might be right for
Glioblastoma (GBM)Brain Metastasases
Nader Sanai 15
Not applicableStudy completedNCT01859845
What this trial is testing

Melanoma Simulation Model With Smartphone Devices: Training Physicians for Early Detection of Melanoma

Who this might be right for
Melanoma
Northwestern University 63
Early research (Phase 1)Study completedNCT00055705
What this trial is testing

PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT03112694
What this trial is testing

Switching From Octreotide to Lanreotide - A Look Back at Patients With Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Ipsen 93
Early research (Phase 1)UnknownNCT03291002
What this trial is testing

Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC

Who this might be right for
Melanoma (Skin)Squamous Cell Carcinoma of the SkinCarcinoma, Squamous Cell of Head and Neck+1 more
CureVac 98
Testing effectiveness (Phase 2)Study completedNCT00001705
What this trial is testing

Immunization of Patients With Metastatic Melanoma Using the GP100 Peptide Preceded by an Endoplasmic Reticulum Insertion Signal Sequence

Who this might be right for
MelanomaNeoplasm Metastasis
National Cancer Institute (NCI) 141
Testing effectiveness (Phase 2)Ended earlyNCT01308294
What this trial is testing

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients

Who this might be right for
Melanoma
Centre Hospitalier Universitaire Vaudois 16
Testing effectiveness (Phase 2)UnknownNCT04029428
What this trial is testing

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 150
Testing effectiveness (Phase 2)UnknownNCT04990271
What this trial is testing

A Clinical Study on the Efficacy and Safety of VEC Intravenous Chemotherapy Combined With Conbercept Intravitreal Injection in the Treatment of Retinoblastoma

Who this might be right for
Retinoblastoma
Chengdu Kanghong Biotech Co., Ltd. 92
Not applicableUnknownNCT01089244
What this trial is testing

FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma

Who this might be right for
AstrocytomaOligoastrocytomaOligodendroglioma
Ludwig-Maximilians - University of Munich 38
Testing effectiveness (Phase 2)Active Not RecruitingNCT05912244
What this trial is testing

IO102/IO103, Nivolumab, and Relatlimab in People With Melanoma

Who this might be right for
Melanoma
Memorial Sloan Kettering Cancer Center 43
Not applicableLooking for participantsNCT06937112
What this trial is testing

18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

Who this might be right for
Lung CancersPancreatic CancerNeuroendocrine Tumors+1 more
Nanjing First Hospital, Nanjing Medical University 20
Not applicableStudy completedNCT00857519
What this trial is testing

The Effectiveness of a Local Injection of Chemotherapy for Retinoblastoma

Who this might be right for
Retinoblastoma
Wills Eye 10
Testing effectiveness (Phase 2)Ended earlyNCT00706992
What this trial is testing

Anti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma Patients

Who this might be right for
Melanoma
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)WithdrawnNCT01115036
What this trial is testing

A Panobinostat Presurgery

Who this might be right for
Recurrent Glioblastoma
Duke University
Next Page